H. Sommer

1.1k total citations
75 papers, 784 citations indexed

About

H. Sommer is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H. Sommer has authored 75 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 27 papers in Cancer Research and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H. Sommer's work include Breast Cancer Treatment Studies (21 papers), Cancer Treatment and Pharmacology (19 papers) and Cancer Cells and Metastasis (11 papers). H. Sommer is often cited by papers focused on Breast Cancer Treatment Studies (21 papers), Cancer Treatment and Pharmacology (19 papers) and Cancer Cells and Metastasis (11 papers). H. Sommer collaborates with scholars based in Germany, Austria and United States. H. Sommer's co-authors include Brigitte Rack, Wolfgang Janni, B. Strobl, Kristin Härtl, M. Stauber, R Kästner, K Friese, Christian Schindlbeck, Ulrich Schmidt and Reinhard J. Boerner and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

H. Sommer

70 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Sommer Germany 15 403 154 150 114 107 75 784
Raquel E. Reinbolt United States 21 594 1.5× 206 1.3× 103 0.7× 132 1.2× 46 0.4× 56 1.1k
Mark S. Clanton United States 8 338 0.8× 180 1.2× 79 0.5× 164 1.4× 52 0.5× 13 895
George Raptis United States 16 801 2.0× 223 1.4× 328 2.2× 136 1.2× 29 0.3× 51 1.5k
Damila Cristina Trufelli Brazil 12 230 0.6× 79 0.5× 86 0.6× 189 1.7× 80 0.7× 27 781
Jawaid Younus Canada 17 276 0.7× 263 1.7× 87 0.6× 99 0.9× 60 0.6× 54 823
P Rissanen Finland 17 364 0.9× 141 0.9× 207 1.4× 59 0.5× 30 0.3× 60 965
Emily Heer Canada 13 538 1.3× 171 1.1× 195 1.3× 187 1.6× 45 0.4× 32 1.0k
Lois Brafman United States 11 832 2.1× 159 1.0× 125 0.8× 88 0.8× 79 0.7× 22 1.2k
Hisham Hamed United Kingdom 13 441 1.1× 148 1.0× 288 1.9× 52 0.5× 24 0.2× 24 975
Donald Fernandes India 15 233 0.6× 372 2.4× 59 0.4× 73 0.6× 229 2.1× 37 748

Countries citing papers authored by H. Sommer

Since Specialization
Citations

This map shows the geographic impact of H. Sommer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Sommer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Sommer more than expected).

Fields of papers citing papers by H. Sommer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Sommer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Sommer. The network helps show where H. Sommer may publish in the future.

Co-authorship network of co-authors of H. Sommer

This figure shows the co-authorship network connecting the top 25 collaborators of H. Sommer. A scholar is included among the top collaborators of H. Sommer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Sommer. H. Sommer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rack, Brigitte, H. Sommer, Wolfgang Janni, et al.. (2016). Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial. Geburtshilfe und Frauenheilkunde. 76(5). 542–550. 7 indexed citations
2.
Scholz, Christoph, Ulrich Andergassen, Philip Hepp, et al.. (2015). Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer. Breast Cancer Research and Treatment. 151(3). 569–576. 38 indexed citations
3.
Mustea, Alexander, Dominique Koensgen, Antje Belau, et al.. (2013). Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology). Cancer Chemotherapy and Pharmacology. 72(5). 975–983. 13 indexed citations
4.
Andergassen, Ulrich, Philip Hepp, Christian Schindlbeck, et al.. (2013). Participation in the SUCCESS-A Trial Improves Intensity and Quality of Care for Patients with Primary Breast Cancer. Geburtshilfe und Frauenheilkunde. 73(1). 63–69. 9 indexed citations
5.
6.
Blohmer, Jens‐Uwe, Peter Schmid, J. Hilfrich, et al.. (2010). Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial. Annals of Oncology. 21(7). 1430–1435. 18 indexed citations
7.
Schmid, Peter, R. Kreienberg, Peter Klare, et al.. (2008). Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial. Cancer Chemotherapy and Pharmacology. 64(2). 401–406. 10 indexed citations
8.
Schindlbeck, Christian, W Janni, Brigitte Rack, et al.. (2005). Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIα-status of the primary tumor?. Journal of Cancer Research and Clinical Oncology. 131(8). 539–546. 13 indexed citations
9.
Helle, Svein Inge, William Mietlowski, Jean Paul Guastalla, et al.. (2005). Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy. European Journal of Cancer. 41(5). 694–701. 7 indexed citations
10.
Hildebrandt, Bert, S. Hegewisch-Becker, Thoralf Kerner, et al.. (2004). Current status of radiant whole-body hyperthermia at temperatures >41.5°C and practical guidelines for the treatment of adults. The German ‘Interdisciplinary Working Group on Hyperthermia’. International Journal of Hyperthermia. 21(2). 169–183. 43 indexed citations
11.
Tiling, Reinhold, M. Keßler, Michael Untch, et al.. (2003). Breast Cancer: Monitoring Response to Neoadjuvant Chemotherapy Using Tc-99m Sestamibi Scintimammography. Oncology Research and Treatment. 26(1). 27–31. 11 indexed citations
12.
Janni, Wolfgang, H. Sommer, B. Strobl, et al.. (2003). Fortschritte in der Früherkennung des Mammakarzinoms in den Jahren 1981 - 1990. DMW - Deutsche Medizinische Wochenschrift. 128(12). 601–606. 2 indexed citations
13.
Härtl, Kristin, Wolfgang Janni, R Kästner, et al.. (2003). Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Annals of Oncology. 14(7). 1064–1071. 170 indexed citations
14.
15.
Janni, Wolfgang, D. Rjosk, B. Strobl, et al.. (2001). Chemotherapieassoziierte Myelosuppression in der gynäkologischen Onkologie. Gyn�kologisch-geburtshilfliche Rundschau. 41(3). 166–173. 5 indexed citations
16.
Tiling, Reinhold, Iraj Khalkhali, H. Sommer, et al.. (1998). Limited value of scintimammography and contrast-enhanced MRI in the evaluation of microcalcification detected by mammography. Nuclear Medicine Communications. 19(1). 55–62. 19 indexed citations
17.
Hebebrand, D., et al.. (1995). Small-Bowel Necrosis Following Laparoscopic Cholecystectomy: a Clinically Relevant Complication?. Endoscopy. 27(3). 281–281. 5 indexed citations
18.
Harrer, G & H. Sommer. (1994). Treatment of mild/moderate depressions with Hypericum. Phytomedicine. 1(1). 3–8. 20 indexed citations
19.
Schmidt, Ulrich & H. Sommer. (1993). [St. John's wort extract in the ambulatory therapy of depression. Attention and reaction ability are preserved].. PubMed. 111(19). 339–42. 10 indexed citations
20.
Mennigen, Rudolf, et al.. (1988). Large bowel tumors and diamine oxidase (DAO) activity in patients: A new approach for risk group identification. Inflammation Research. 23(3-4). 351–353. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raquel E. Reinbolt Breakdown of academic impact, for papers by Mark S. Clanton Breakdown of academic impact, for papers by George Raptis Breakdown of academic impact, for papers by Damila Cristina Trufelli Breakdown of academic impact, for papers by Jawaid Younus Breakdown of academic impact, for papers by P Rissanen Breakdown of academic impact, for papers by Emily Heer Breakdown of academic impact, for papers by Lois Brafman Breakdown of academic impact, for papers by Hisham Hamed Breakdown of academic impact, for papers by Donald Fernandes
Rankless by CCL
2026